NGNE
Neurogene Inc.
$33.23
+$1.61(+5.08%)
55
Overall
--
Value
83
Tech
28
Quality
Market Cap
$334.96M
Volume
139.01K
52W Range
$6.88 - $74.49
Target Price
$47.40
EPS Estimates Overview
| Current Quarter | $-1.26 | Next Quarter | $-1.29 |
| Current Year | $-4.74 | Next Year | $-5.98 |
| QoQ Growth | -2.4% | YoY Growth | -26.2% |
| 3Y EPS CAGR | +0.9% | Target Price | $47.40 |
| Consensus | Buy | Upside | +42.7% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NGNE | $33.23 | +5.1% | 139.01K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |